Andrew J. Zganjar, M.D.

  1. Oncologist
  2. Surgeon
  3. Urologist
  1. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. Reply by Authors. J Urol 2024 Oct; 212 (4):559 Epub 2024 July 30
    View PubMed
  2. Khanna A, Gottlich HC, Dorr M, Lohse CM, Zganjar A, Sharma V, Joyce D, Potretzke A, Britton C, Rule AD, Boorjian SA, Leibovich BC, Thompson RH. End-Stage Kidney Disease After Partial and Radical Nephrectomy Among Patients With Severe Chronic Kidney Disease. J Urol. 2024 Oct; 212 (4):550-559 Epub 2024 June 27
    View PubMed
  3. Wu SY, Gibbs EM, Klose C, Qosja N, Zganjar A, Baird BA. Conservative management of segmental testicular infarction in a patient with sickle cell anemia: A case report. Urol Case Rep. 2024 Sep; 56:102775 Epub 2024 June 21
    View PubMed
  4. Klose C, Gibbs M, Kahn A, Baird B, Farres S, Zganjar A. Diagnosis and open excision of concurrent pelvic schwannoma and chromophobe renal cell carcinoma. Urol Case Rep. 2024 Sep; 56:102809 Epub 2024 July 22
    View PubMed
  5. Britton CJ, Sharma V, Zganjar A, Lohse CM, Cheville JC, Houston Thompson R, Leibovich BC, Boorjian SA, Potretzke AM. Evaluation of American Urological Association Renal Cell Carcinoma Risk Groups for Chromophobe Renal Cell Carcinoma. Urology. 2024 Aug 10 [Epub ahead of print]
    View PubMed
  6. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J Urol. 2024 Aug; 212 (2):331-341 Epub 2024 May 30
    View PubMed
  7. Zganjar A, Khanna A, Joyce D, Nichols P, Britton C, Lohse CM, Cheville JC, Gupta S, Potretzke AM, Thompson RH, Leibovich BC, Boorjian SA, Sharma V. Reply by Authors. J Urol 2024 Aug; 212 (2):341 Epub 2024 May 30
    View PubMed
  8. Hensley PJ, Labbate C, Zganjar A, Howard J, Huelster H, Durdin T, Pham J, Xiao L, Pallauf M, Lombardo K, Glezerman I, Singla N, Raman JD, Coleman J, Spiess PE, Margulis V, Potretzke AM, Matin SF. Development and Validation of a Multivariable Nomogram Predictive of Post-Nephroureterectomy Renal Function. Eur Urol Oncol. 2024 Feb 1 Epub 2024 Feb 01
    View PubMed
  9. Lee YS, Schommer J, Borkar S, Brennan E, Zganjar A, Colibaseanu DT, Spaulding AC, Lyon TD. Features associated with travel distance for radical cystectomy in Florida: Implications for access to care. Urol Oncol. 2023 Dec; 41 (12):485.e9-485.e16 Epub 2023 July 18
    View PubMed
  10. Geldmaker LE, Zganjar AJ, Gonzalez Albo GA, Haehn DA, Qosja N, Wieczorek MA, Ball CT, Thiel DD. Impact of Inner Layer Renorrhaphy Suture on Renal Artery Pseudoaneurysm Formation Following Robotic-assisted Partial Nephrectomy. Urology. 2023 Dec; 182:125-132 Epub 2023 Sept 04
    View PubMed
  11. Zganjar AJ, Thiel DD, Lyon TD. Diagnosis, workup, and risk stratification of upper tract urothelial carcinoma. Transl Androl Urol. 2023 Sep 30; 12 (9):1456-1468 Epub 2023 Aug 04
    View PubMed
  12. Rodrigues Pessoa R, Zhang H, Zganjar A, Nabavizadeh R, Packiam VT, Lohse CM, Cheville JC, Pagliaro LC, Costello BA, Boorjian SA, Thompson RH, Lucien F, Dong H, Leibovich BC. Circulating antigen-primed cytotoxic T-cells in patients with renal tumors treated with surgery. Urol Oncol. 2023 Sep; 41 (9):393.e1-393.e7 Epub 2023 July 04
    View PubMed
  13. Zganjar A, Toussi A, Ziegelmann M, Frank I, Boorjian SA, Tollefson M, Kohler T, Trost L. Efficacy of RestoreX after prostatectomy: open-label phase of a randomized controlled trial. BJU Int. 2023 Aug; 132 (2):217-226 Epub 2023 May 09
    View PubMed
  14. Baird B, Bilgili A, Anderson A, Carames G, Pathak RA, Ball CT, Pak R, Zganjar A, Young PR, Lyon TD. Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer. Int Braz J Urol. 2023 Jul-Aug; 49 (4):479-489
    View PubMed
  15. Baird BA, Taylor T, Brennan E, Borkar S, Anderson A, Boorjian SA, Zganjar A, Colibaseanu DT, Spaulding AC, Lyon TD. Disparities in access to high-volume centers and in hospital discharge status following radical cystectomy in Florida. Urol Oncol. 2023 Jun; 41 (6):294.e19-294.e26 Epub 2022 Dec 16
    View PubMed
  16. Lyon TD, Pathak RA, Zganjar AJ. Editorial Comment. J Urol 2023 May; 209 (5):870-871 Epub 2023 Feb 24
    View PubMed
  17. Gupta S, Nichols P, Lohse CM, Kosari F, Kattah AG, Harris FR, Karagouga G, Mehra R, Fine SW, Reuter VE, Herrera-Hernandez L, Zganjar AJ, Britton CJ, Potretzke AM, Boorjian SA, Thompson RH, Jimenez RE, Leibovich BC, Garovic VD, Cheville JC, Sharma V. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. Mayo Clin Proc. 2022 Nov; 97 (11):2050-2064 Epub 2022 June 24
    View PubMed
  18. Valiquette AM, Graf AR, Mickschl DJ, Zganjar AJ, Grindel SI. Rotator cuff repair in upper extremity ambulators: an assessment of longitudinal outcomes. JSES Int. 2022 Nov; 6 (6):942-947 Epub 2022 Sept 15
    View PubMed
  19. Khanna A, Miest T, Sharma V, Campbell R, Hensley P, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Murthy PB, Haber GP, Navai N, Kamat AM, Dinney C, Lee B, Boorjian SA. Role of Lymphadenectomy during Radical Cystectomy for Nonmuscle-Invasive Bladder Cancer: Results from a Multi-Institutional Experience. J Urol. 2022 Mar; 207(3):551-558. Epub 2021 Oct 25.
    View PubMed
  20. Miest T, Khanna A, Sharma V, Hensley PJ, Campbell R, Thapa P, Zganjar A, Tollefson MK, Thompson RH, Frank I, Karnes RJ, Potretzke A, Matin SF, Murthy PB, Haber GP, Lee B, Boorjian SA. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy. J Urol. 2022 Feb; 207(2):284-292. Epub 2021 Sep 22.
    View PubMed
  21. Miest T, Khanna A, Sharma V, Hensley P, Campbell R, Thapa P, Zganjar A, Tollefson M, Thompson RH, Frank I, Karnes RJ, Potretzke A, Matin S, Murthy P, Haber G, Lee B. Upper Tract Urothelial Carcinoma Following Radical Cystectomy: A Risk-Adapted Scoring Model for Stratifying Surveillance Intensity Journal of Urology. 2021.
  22. Khanna A, Zganjar A, Lyon T, Shah P, Tollefson MK, Karnes RJ, Tarrell R, Thapa P, Thompson RH, Frank I, Boorjian SA. A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy. J Urol. 2021 Oct; 206 (4):970-977 Epub 2021 May 25
    View PubMed
  23. Zganjar A, Glavin K., Man K, Dahlgren A, Thompson J, Wulff-Burchfield E, Wyre H, Taylor J, Lee E, Holzbeierlein J, Mirza M. Intensive Preoperative Ostomy Education for the Radical Cystectomy Patient ”Urologic Oncology: Seminars and Original Investigations. 2021.
  24. Ellis S, Geana M, Griebling T, McWilliams C, Gills J, Stratton K, Mackay C, Shifter A, Zganjar A, Thrasher B. Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices Trials. 2019; 7;20(1):578:578.
  25. Zganjar A, Nangia A, Sokol R, Ryabets A, Samplaski M. Fertility in Adolescents with Klinefelter Syndrome–A Survey of Current Clinical Practice” Journal of Clinical Endocrinology & Metabolism J Clin Endocrinol Metab. 2019.
  26. Ellis S, Geana M, Mackay C, Moon D, Zganjar A, Gills J. Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices Urol Oncol. 2019; 37(8):529.e9-529.e18:529.e9-529.e18.
  27. Grimstad F, Le M, Zganjar A, Flores D, Gourley E. An Evaluation of Reported Follicle Stimulating Hormone, Luteinizing Hormone, Estradiol and Prolactin Reference Ranges in the United States UROLOGY. 2018; Volume 120:Pages 114-119.